Editor’s note

Testing the new FDI norms

The Modi government’s reforms have tinkered with FDI norms twice, first in November 2015 and more recently in June this…

Turning threat into opportunity

It is human nature to perceive change as a threat. But turning this threat into an opportunity is a crucial…

Embracing quality as an opportunity

Concerned with declining pharma exports in the recent past, the Ministry of Commerce & Industry has tried to burnish the…

To switch or not to switch …

A notice dated March 30 from the Drug Controller General (India) asking for ‘science-based suggestions/ comments’ on the pros and…

Weeding out the bad FDCs

The fixed dose combination (FDC) issue has been a contentious one for years and on March 10 came back to…

Once again, nothing much for pharma

In his third budget, Finance Minister Arun Jaitley has taken one more shot at a balancing act between maintaining fiscal…

Public health: In need of Nari Shakti

As we mark yet another Women’s Day this March, here are some sobering words from Sanghita Bhattacharyya, Senior Public Health…

Acche Din Kab Aayenge?

All eyes are once again on India’s Finance Minister Arun Jaitley as he prepares to present the Modi Government’s second…

WL dims Sun’s shine … a bit

A new year brings with it new hope but all indications are that 2016 is going to be a mixed…

Of laws and flaws

Could New Jersey Superior Court’s decision this October be a wake up call for Indian companies with global ambitions

Sifting the trends into 2016

If the latest edition of the Antal Global Snapshot (AGS) on annual global hiring and firing trends is any indicator,…

Finding the hidden gems

Vishal Jajodia could sign up as a poster boy for Prime Minister Narendra Modi’s Make In India campaign

Balancing the scales

Besides the balanced reasoning within the Delhi HC judgement, it is the SC’s intervention which could see this case go…

Mainstreaming AYUSH

The last month saw a major milestone in the patent versus patient debate